Response at 4 GBV induction cycles
| Lugano CT scan based∗ | n | % | 90% CI |
| Overall response | 33 | 46.5 | 36.30-56.89 |
| CR | 14 | 19.7 | 12.33-29.1 |
| PR | 19 | 26.7 | 18.29-36.75 |
| Stable disease | 4 | 5.6 | 1.95-12.43 |
| Progressive disease | 27 | 38.0 | 28.37-48.46 |
| Death | 3 | 4.2 | 1.16-10.56 |
| Nonevaluable† | 4 | 5.6 | 1.95-12.43 |
| Lugano PET scan based | n | % | 90% CI |
| Overall metabolic response | 32 | 45.1 | 34.96-55.50 |
| Complete metabolic response | 17 | 23.9 | 15.87-33.72 |
| Partial metabolic response | 15 | 21.1 | 13.50-30.65 |
| Progressive metabolic disease | 11 | 15.5 | 8.94-24.34 |
| Missing‡ | 28 | 39.4 | 29.68-49.88 |
| Lugano CT scan based∗ | n | % | 90% CI |
| Overall response | 33 | 46.5 | 36.30-56.89 |
| CR | 14 | 19.7 | 12.33-29.1 |
| PR | 19 | 26.7 | 18.29-36.75 |
| Stable disease | 4 | 5.6 | 1.95-12.43 |
| Progressive disease | 27 | 38.0 | 28.37-48.46 |
| Death | 3 | 4.2 | 1.16-10.56 |
| Nonevaluable† | 4 | 5.6 | 1.95-12.43 |
| Lugano PET scan based | n | % | 90% CI |
| Overall metabolic response | 32 | 45.1 | 34.96-55.50 |
| Complete metabolic response | 17 | 23.9 | 15.87-33.72 |
| Partial metabolic response | 15 | 21.1 | 13.50-30.65 |
| Progressive metabolic disease | 11 | 15.5 | 8.94-24.34 |
| Missing‡ | 28 | 39.4 | 29.68-49.88 |
Primary end point.
Related to premature withdrawal for early PD (n = 3) or for AE after 1 cycle (n = 1)
Related to overt (clinically and/or on CT scan) disease progression (no PET-CT done; n = 21), deaths (n = 3), premature withdrawal after 4 cycles for adverse event (n = 2), or other reason (n = 2).